分类: health

  • Two children admitted to hospital after contracting bacterial infection from Melbourne petting zoo

    Two children admitted to hospital after contracting bacterial infection from Melbourne petting zoo

    An ongoing investigation by Victoria’s Department of Health has been launched after an outbreak of shiga toxin-producing Escherichia coli (STEC), a dangerous foodborne and zoonotic bacterial pathogen, linked to a Melbourne petting zoo left two young children hospitalized, with one facing lifelong health impacts and a potential kidney transplant.

    Four weeks ago, a 3-year-old child was admitted to Monash Children’s Hospital following infection contracted during a visit to the interactive animal attraction. The toddler has already developed permanent brain damage and acute kidney failure, with clinical teams indicating a kidney transplant may be necessary to sustain long-term health. A second infected child, aged 2, spent more than two weeks receiving life-sustaining dialysis at the same hospital unit after falling ill from the same outbreak.

    According to Australia’s Centre for Disease Control (CDC), STEC bacteria naturally reside in the gastrointestinal tract and faeces of many animals, with cattle being the most common carrier. The agency records more than 1,000 confirmed STEC infections across the country annually, and the pathogen can trigger severe gastrointestinal distress and catastrophic kidney dysfunction in vulnerable populations. In the most serious cases, STEC infection progresses to haemolytic uraemic syndrome (HUS), a life-threatening condition that destroys red blood cells and causes irreversible kidney damage. Both STEC infection and HUS disproportionately affect children under five years old, and no vaccine currently exists to prevent infection.

    Typical symptoms of STEC infection, including watery or bloody diarrhoea, abdominal cramping, nausea, and vomiting, develop three to four days after initial exposure. Infected children can carry and spread the bacteria for up to three weeks, while adults typically remain contagious for approximately one week. The CDC confirms that direct contact with animals at petting zoos and farms is a well-documented transmission route, but infection can also occur through swallowing contaminated recreational water, or consuming contaminated food or beverages.

    Victoria’s Chief Health Officer Caroline McElnay has issued a public warning urging parents and caregivers to prioritize rigorous hand hygiene to reduce infection risk. “Good hand hygiene is one of the most effective ways to protect yourself and your family from infections that can, in rare cases, lead to serious illness such as haemolytic uraemic syndrome,” McElnay stated. “While HUS is very rare, young children can become seriously unwell, so it’s important to wash your hands, and help children wash theirs, after using the toilet and after contact with animals.”

    The Department of Health’s investigation into the source and scope of the outbreak remains ongoing as of press time.

  • New trend of injecting banned peptides to ‘optimise’ body

    New trend of injecting banned peptides to ‘optimise’ body

    A growing global trend of unregulated, banned peptide injection among fitness enthusiasts and aspiring bodybuilders is raising urgent red flags from medical and scientific experts, who warn the untested practice carries severe, underreported health risks.

    For 29-year-old aspiring bodybuilder Thomas (a pseudonym to protect his identity), based in France where the substances he uses are outlawed, injecting peptides has become a fixed part of his daily routine. Every evening at 9:30 p.m., his phone alarm reminds him to mix and self-administer two banned synthetic peptides into his lower abdomen: daily doses of GHK-Cu, which he says improves skin quality, and Retatrutide, taken three times weekly to curb appetite. Six months after first trying peptides while already using steroids, Thomas has added two more unapproved substances to his regimen: Selank to ease anxiety, and BPC-157, marketed to speed up soft tissue and ligament repair after gym workouts.

    Since France bans the sale and use of these peptides, no official dosage guidelines or safety protocols exist. Like hundreds of other mostly male users, Thomas gets his advice from anonymous online communities on Reddit and Discord, where users swap anecdotes about dosing and claimed benefits. “It takes a little organisation, but it’s become a routine,” Thomas told Agence France-Presse, adding he dismisses warnings of risk, which he calls “rare and not serious.”

    Thomas is far from alone. Driven by viral social media content from influencers, celebrities and the unregulated wellness industry, peptides are being widely marketed as a miracle solution for everything from anti-aging and clearer skin to muscle growth, improved sleep and sharper cognitive function. The narrative of “biological optimization” pushed online frames the human body as a form of capital that can be upgraded with chemical supplements, attracting growing numbers of people willing to self-experiment with untested substances.

    Peptides themselves are not inherently dangerous: short chains of amino acids that form proteins, they occur naturally in the human body and regulate critical processes like tissue repair. Lab-synthesized peptides are also approved as active ingredients in many common medications, including insulin and popular GLP-1 weight loss drugs. But the unregulated, unauthorized versions sold via gym networks and online marketplaces have never undergone rigorous clinical testing to confirm their claimed benefits or safety.

    French national research institute INSERM stresses that no large-scale, randomized controlled human trial has ever validated the sweeping benefits marketed for unapproved peptides. Neuroscientist Armelle Rancillac of INSERM noted most of these compounds have never even been tested on human subjects, leaving even experienced users with no accurate understanding of correct dosing or long-term side effects. Claims from online self-experimenters, she argued, are scientifically worthless and are given far too much credibility by audiences eager for quick physical results.

    The warnings are backed by documented hospitalizations linked to unregulated peptide use. Earlier this year, Australian health authorities confirmed six cases of acute liver injury directly tied to Retatrutide-containing products. While exact data on how many people use unapproved peptides is hard to collect, Swiss University of Lausanne sports sociologist Fabien Ohl told AFP the sharp rise in exposure alone is enough to “raise alarm.”

    Ohl also criticized the harmful ideological underpinning of the trend: the online framing of masculinity that ties male worth to physical optimization via chemical enhancement, which he says normalizes a dangerous ideal of “the biological male who is potentially more violent and aggressive.”

    The regulatory landscape around peptides remains fractured. Many countries, including France, ban unapproved synthetic peptides entirely due to safety concerns, but the issue has become contentious in the United States. Last month, a federal advisory panel made a controversial recommendation to loosen restrictions on a range of unapproved peptides. The decision drew fierce backlash from the medical community, which accuses US Health Secretary Robert F. Kennedy Jr. — an avowed public user and fan of peptides — of stacking the panel with industry-linked allies to push for deregulation.

  • Congo’s fastest-growing Ebola outbreak reaches a sixth province

    Congo’s fastest-growing Ebola outbreak reaches a sixth province

    KINSHASA, Democratic Republic of Congo – The ongoing deadly Ebola outbreak in eastern Democratic Republic of Congo has expanded into a sixth previously unaffected province, with the first fatality recorded in Bas-Uele, Africa Centres for Disease Control and Prevention Director-General Jean Kaseya confirmed Thursday.

    The deceased patient, Kaseya explained, had traveled from Isiro, a community in the already impacted Haut-Uele province, to Buta – the capital city of Bas-Uele – before succumbing to the virus.

    The World Health Organization warned Wednesday that this current outbreak, driven by the rare Bundibugyo strain of Ebola, is already the fastest-growing event of its kind on record and is on course to surpass the 2013-2016 West African outbreak, the deadliest Ebola event in history that claimed more than 11,000 lives. Unlike outbreaks of more common Ebola strains, there are currently no formally approved vaccines or targeted treatments available for the Bundibugyo variant driving the current surge.

    Latest official data from the Congolese government puts the outbreak’s cumulative case count above 4,500, with more than 2,100 deaths recorded to date. Alarmingly, this death toll has been reached nearly three times faster than the same mortality milestone during the 2014-2016 West African outbreak, signaling an unprecedented rate of spread.

    Response efforts are being severely hampered by a perfect storm of systemic and security challenges. Unpaid health workers have launched widespread strikes, armed rebel groups operate in many affected regions, deep-seated distrust among long-traumatized local communities undermines containment work, and pervasive misinformation claiming Ebola does not exist has discouraged participation in public health measures. These barriers have allowed the virus to outpace intervention teams across the country.

    On the same day the expansion to Bas-Uele was announced, health workers at the Nizi Treatment Center in Ituri – the hardest-hit province in the outbreak – walked off the job, forcing the facility to temporarily close. Workers reported they had not received any salary for three months, a grievance that has disrupted care across multiple response sites.

    Compounding the crisis, the true scale of the outbreak remains undercounted and poorly understood. Though the outbreak was formally declared on May 15, recent genetic sequencing conducted by the WHO confirms the virus was circulating as early as February, months before official detection. Health authorities estimate that 60 to 70 percent of new confirmed cases are found among community members not already on monitored contact lists, confirming the virus is spreading widely through undetected community transmission.

    “We are chasing the virus; the virus is ahead of us,” Dr. Mohamed Yakub Janabi, the WHO Regional Director for Africa, stated this week, summarizing the growing gap between spread and response.

    Ebola is a rare but highly contagious viral pathogen that spreads through direct contact with infected bodily fluids including blood, vomit and semen, as well as exposure to contaminated surfaces and materials like bedding and clothing. Infection causes severe acute illness that carries a high risk of fatality without targeted care.

    In a small bright spot for the response, clinical trials for two potential treatments specific to this strain of Ebola launched last month in Ituri, offering hope that targeted medical options could become available in the coming months.

  • USAID fallout: In Nepal, when the aid workers stopped coming, the women and babies started dying

    USAID fallout: In Nepal, when the aid workers stopped coming, the women and babies started dying

    In the parched, poverty-stricken villages of Nepal’s Rautahat district, a preventable tragedy unfolded in late 2025 that encapsulates the global human cost of sweeping U.S. foreign aid cuts. Twenty-year-old Kabita Mukhiya, a young mother of three who dreamed of giving her unborn son the education she never had, suffered for weeks from unexplained abdominal agony and swelling during her 28-week pregnancy. Uneducated, impoverished, and abandoned by the community outreach workers who once monitored at-risk pregnant women in her village, Kabita did not know she was experiencing life-threatening complications. When her aunt finally carried her to a hospital, it was too late: her unborn baby was dead, and Kabita herself died hours later from untreated eclampsia and severe anemia, conditions that routine prenatal care could have detected and managed.

    Kabita’s death is not an isolated incident. It is one of hundreds of preventable maternal and child fatalities documented by the Associated Press across the globe following the Trump administration’s decision to dissolve the United States Agency for International Development (USAID), for decades the world’s largest single provider of humanitarian assistance. The U.S. funding cuts, which shuttered life-saving maternal and neonatal health programs, eliminated nutritional support for pregnant people and young children, and idled thousands of community outreach workers, have been followed by additional aid reductions from other donor nations. The World Health Organization (WHO) estimates that 60% of women’s health organizations globally have been forced to slash critical services as a result.

    Global public health experts are already bracing for a devastating turning point. The Bill & Melinda Gates Foundation projects that 2025 will be the first year of this century to see an increase in global child mortality, reversing decades of steady progress in reducing preventable deaths. A study published in *The Lancet* warns that the U.S. aid cuts could lead to more than 14 million excess deaths by 2030, including over 4.5 million deaths of children under age 5. WHO’s Rajat Khosla, executive director of the Partnership for Maternal, Newborn and Child Health, calls the reversal catastrophic: “It’s heartbreaking to see what’s happening. It’s decades of progress being washed away.”

    In response to AP’s reporting, the U.S. State Department defended the administration’s policy, stating that the restructuring refocuses assistance on efficiency, effectiveness, and global partnership. The department noted that the U.S. still spends more on health and humanitarian aid than any other nation, and continues to support maternal and child health programs in Nepal, adding that “the rest of the world needs to contribute more and share the burden.”

    On the ground in Nepal, however, local health workers and aid organizations say the impact of the cuts has already been catastrophic. CARE Nepal, one of the largest aid groups operating in the country, lost more than half of its funding from the U.S. cuts. “The number of deaths of mothers, young mothers, during delivery has really increased,” said Mona Sherpa, CARE Nepal’s country director. “The expected number within a year is happening within four to six months.”

    Prior to the cuts, USAID funded a five-year, $35 million maternal and child health initiative in Nepal that reached more than 100,000 women and girls in its first three years. The program equipped rural birthing centers with life-saving equipment and medications, trained nurses and midwives, and supported a network of female community health volunteers who made regular home visits to pregnant women. These volunteers identified warning signs of complications, helped women schedule and access prenatal appointments, and explained critical medical information in terms local communities could understand.

    When the program was shut down, the volunteer network collapsed. In Dewahi Gonahi municipality, the head of the local birthing center, Kishori Shah, reports that the number of women attending prenatal checks has dropped by 50% since the cuts. Without early screening, complications that could be easily managed are left to escalate into life-threatening emergencies. “There would have been a decrease in complications if the USAID program was still running,” Shah says.

    In Prempur Gonahi village, the reversal of progress is stark. Before the program launched in 2022, the village saw an average of 10 to 15 neonatal deaths per year. By 2024, that number had dropped to zero. Just 10 months after the program was canceled, newborn deaths began to climb again: one in December 2025, four more by March 2026.

    Many of these deaths will never be officially counted: the aid cuts also eliminated funding for mortality data collection, leaving vast stretches of rural Nepal without anyone to track and report preventable deaths. Campaign Nepal, a local partner of CARE, has documented eight infant deaths in Dewahi Gonahi since the cuts, but official government records list only two. “There must be more than that,” says Shatrudhan Singh, Campaign Nepal’s executive director. “We just can’t identify them.”

    Another young woman from the region, 19-year-old Phula Devi, shared her story of grief with the AP, one she had never told even her own husband. Uneducated and with no outreach worker to guide her, Phula did not understand the warning that her unborn baby had a slow heartbeat, and delayed going to the hospital at the direction of her relatives. When she arrived, doctors urged a C-section to deliver her overdue baby, but Phula did not understand the procedure and was terrified. She delivered the baby on her own, and he was stillborn. “I think of my baby all the time,” Phula says, hiding her tear-streaked face behind a scarf. “She would have done anything to save him, if she’d only known how.”

    For Kabita Mukhiya, the collapse of outreach services proved fatal. When she was pregnant with her third child, Yubraj, she received free nutritional supplements from the U.S.-funded program that helped offset her family’s meager diet, which provided barely enough to eat. By the time she became pregnant with her fourth child, the supplements were gone, along with the regular mother’s health meetings she had attended. She missed her first-trimester checkup entirely, and only showed up for her first screening at 16 weeks. Her nurse noticed she was dangerously pale and urged her to get a blood test to check for anemia, but Kabita did not understand why the test was necessary, and never got it. By the time she arrived at the hospital, her condition was irreversible.

    Rajkumari Patel, one of the community health volunteers who lost her job when the program was cut, says Kabita’s death is exactly what she was trained to prevent. “I used to know every pregnant woman in her village, visiting them at home,” Patel says. “I would have asked her, ‘Is the baby kicking? When did you last feel movement?’ I would have checked for swelling in her hands and face. I would have looked at her eyes for signs of anemia. These are the signs I would have noticed in Kabita and said, ‘This woman needs a hospital today — not tomorrow.’ Maybe we could have saved her life.”

    Nutrition data from the region confirms the widespread damage of cutting support programs. Before the U.S. cuts, the prevalence of life-threatening wasting (severe malnutrition) among children under five in Kabita’s province was 7.4%. A national screening conducted in May 2026 found that rate has jumped to 12.3% after the cuts eliminated most local nutrition support programs.

    In the months since Kabita’s death, her family has been left to pick up the pieces. Her husband, who was working construction in India when she died, arrived home three days after her funeral, and has been inconsolable, often refusing to work for days at a time. Kabita’s 60-something mother-in-law and aunt are now left to care for her three young children, ages 1, 3, and 5, with barely enough income to put rice on the table. “How will I feed them? I’m old,” says Lachhiya Devi, Kabita’s mother-in-law, as she strokes the leg of her sleeping 4-year-old granddaughter. “You can see how desperately I’m trying to get by.”

    Kabita’s aunt Shraddha, who carried her to the hospital and watched her take her final breath, says the tragedy could have been avoided entirely if outreach workers had still been in place to guide the village’s vulnerable women. “We don’t have anyone to help us out here, to tell us about these things. If there was someone, we would ask them, follow their advice,” she says. “It would have saved her life. She was too young to die.”

  • Ebola outbreak on track to be deadliest ever, WHO chief says

    Ebola outbreak on track to be deadliest ever, WHO chief says

    The world faces a rapidly escalating public health crisis in the eastern Democratic Republic of Congo (DRC), where the 2026 Ebola outbreak is projected to become the deadliest in recorded history if current infection trends hold, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus has announced.

    Speaking to reporters, Tedros explained that at the current rate of transmission, the outbreak will eclipse the devastating 2014-2016 West African Ebola epidemic, which claimed more than 11,000 lives across the region. As of the latest WHO update, the 2026 outbreak – officially declared on May 15 – has already confirmed at least 4,300 cases and recorded over 2,000 deaths.

    While the WHO has set an ambitious goal to reverse the outbreak’s spread within a three-month window, agency officials have stressed that this target only refers to bringing community transmission under control, not eradicating the virus entirely. A key complicating factor that has fueled the outbreak’s rapid growth is its unrecognized early spread: health officials confirmed this week that the virus began circulating as early as February, three full months before the outbreak was formally declared. Early cases were misdiagnosed as more common local illnesses, including malaria and typhoid, allowing undetected transmission to continue for months.

    “We are chasing the virus, and the virus is ahead of us,” Dr Mohamed Janabi, WHO Regional Director for Africa, told reporters during a press briefing in Bunia, the DRC city closest to the outbreak’s epicenter.

    Compounding challenges for frontline response teams, the 2026 outbreak is caused by the rare Bundibugyo strain of Ebola, a variant that has only been linked to two small, previously documented outbreaks in 2007 and 2012. No vaccines or antiviral therapies have received full regulatory approval specifically for this strain, leaving response teams with no standard, proven tools to stop transmission or treat infected patients.

    Widespread regional instability in eastern DRC has further undermined containment efforts, Janabi added. Ongoing conflict has restricted access to affected communities, meaning health workers can only reach roughly 30% of confirmed cases to provide care and implement infection control measures.

    Ebola is an extremely virulent viral pathogen with a high mortality rate. Symptoms develop between 2 and 21 days after initial exposure, beginning with sudden flu-like manifestations including fever, headache and fatigue that easily mimic more common tropical illnesses like malaria. As infection progresses, patients develop severe vomiting and diarrhea, often leading to acute organ failure and death. The virus spreads between humans through direct contact with infected bodily fluids, such as blood or vomit.

    Despite the severe challenges, there are emerging signs of progress in research and development for targeted countermeasures. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted regulatory approval to launch the first human clinical trials for an investigational Bundibugyo Ebola vaccine. The candidate is being developed by a research team at the University of Oxford, built on the same stable mRNA-vectored platform that powered the Oxford-AstraZeneca COVID-19 vaccine. Three additional independent research groups are also working on alternative Bundibugyo vaccine candidates, though those are still in pre-clinical development and have not yet entered human testing.

    Separately, the WHO is sponsoring a clinical trial based in the DRC to test whether two existing antiviral therapies can improve survival rates for patients infected with the Bundibugyo strain, as global health authorities work to scale up evidence-based care while long-term vaccine development progresses.

  • WHO says Congo’s Ebola outbreak is on track to eclipse the deadliest one in history

    WHO says Congo’s Ebola outbreak is on track to eclipse the deadliest one in history

    GENEVA – The head of the World Health Organization issued a stark warning Wednesday that the ongoing Ebola outbreak in the Democratic Republic of the Congo is on course to become the deadliest Ebola epidemic on record, surpassing the 2014-2016 West African outbreak that claimed more than 11,000 lives across over 28,000 confirmed cases.

    Speaking to reporters gathered in Geneva, WHO Director-General Tedros Adhanom Ghebreyesus emphasized that based on the current rate of new infections and fatalities, the eastern Congo outbreak will soon overtake the historic 2014-2016 event as the worst Ebola outbreak the world has ever seen.

    Already, the outbreak – which public health officials classify as the fastest-growing in recorded history – has documented more than 4,300 confirmed cases and claimed more than 2,000 lives, according to WHO data. While the outbreak was not formally declared by Congolese health authorities until May 15, recent genetic sequencing analysis of virus samples has traced the first infections back to February, meaning the outbreak has been spreading undetected in local communities for months before an official response was launched.

    What makes this outbreak particularly challenging for frontline health workers is the unique strain of virus driving it: the rare Bundibugyo Ebola variant, for which no licensed vaccines or targeted antiviral treatments currently exist. This leaves medical teams limited in their ability to protect at-risk populations and improve outcomes for infected patients.

    Compounding these challenges is the geographic and security context of the outbreak. The virus is spreading across remote, conflict-ravaged regions of eastern Congo, close to the country’s shared borders with South Sudan, Uganda, and Rwanda – a location that raises the risk of cross-border transmission to neighboring countries. Epidemiologists tracking the outbreak note that the virus is spreading more quickly than response teams can scale up their monitoring and containment efforts. A majority of new cases and deaths continue to occur in local communities that remain inaccessible to health workers, allowing the virus to spread undetected and unchallenged.

  • Fact-checking Trump’s claims as he rolls back some recommended vaccines

    Fact-checking Trump’s claims as he rolls back some recommended vaccines

    On Monday, former U.S. President Donald Trump signed an executive order in the Oval Office that alters the national recommended childhood vaccine schedule, cutting the number of vaccine-preventable diseases covered from 18 to 11 and recommending that the combined mumps, measles and rubella (MMR) vaccine be split into separate individual doses. However, during the signing ceremony, Trump made a series of misleading and outright false statements about childhood vaccinations that have been widely refuted by public health experts and leading federal health agencies.

    One of Trump’s most high-profile false claims was that federal policy required young children to receive as many as 72 vaccine doses. White House Press Secretary Karoline Leavitt amplified this claim after the announcement by sharing a graphic showing an infant surrounded by needles labeled “72 injections”. Fact-checkers quickly confirmed that this framing is deeply inaccurate on multiple counts. First, while federal vaccine guidance influences policies across the country, requirements for school entry are set individually by U.S. states, meaning the total number of doses administered to children varies by location. Second, the 72-dose count cited by the White House tallies every potential vaccine dose a person could receive between birth and age 18, including annual influenza shots and routine COVID-19 boosters — not doses given only to young children or infants.

    Trump also made a false claim about the volume of vaccine doses administered, stating that a single MMR shot contains an amount of liquid comparable to an entire bottle of soda. According to U.S. Food and Drug Administration (FDA) data, a standard single dose of MMR is just 0.5 milliliters, which equals a tiny fraction of a single teaspoon. Josh Michaud, associate director of the Global and Public Health Policy Program at the Kaiser Family Foundation (KFF), confirmed that even the combined total volume of all vaccines recommended for childhood is nowhere close to the volume of a bottle of soda, and is dramatically smaller than Trump’s description.

    When arguing for splitting the combined MMR vaccine into three separate doses, Trump claimed that combining the three vaccines into a single shot “could be a possibility they’re quite lethal”. This claim directly contradicts decades of public health data collected by the U.S. Centers for Disease Control and Prevention (CDC). The CDC confirms that the vast majority of people who receive the combined MMR vaccine experience no serious adverse reactions. Getting vaccinated against the three diseases is also far safer than contracting measles, mumps, or rubella, all of which can cause severe long-term illness and even death. The most serious potential side effects of MMR vaccination are febrile seizures and severe allergic reactions, both of which the CDC classifies as extremely rare; only one in 3,000 to 4,000 vaccinated children experience a febrile seizure after vaccination.

    Finally, Trump repeated the long-debunked claim that vaccines are linked to rising autism diagnosis rates, claiming that autism rates have grown in lockstep with expanded vaccine schedules and citing a wildly inaccurate historical rate of one case per 10,000 people 20 years prior. While autism diagnosis rates in the U.S. have indeed risen over the past two decades, the growth has not matched Trump’s claims: the CDC estimated a rate of one in 110 children in 2006, which rose to one in 88 just two years later. Leading public health experts overwhelmingly agree that rising diagnosis rates are explained by broader changes to diagnostic criteria, increased public awareness of autism, and expanded access to screening, not any change in vaccine schedules.

    Decades of large-scale peer-reviewed studies have found no causal link between vaccination and autism. Most recently, a comprehensive 2025 review conducted by the World Health Organization (WHO) analyzed data from dozens of independent studies covering millions of children across multiple countries, and formally concluded there is no causal connection between vaccination and autism. Experts explain that the false public perception of a link stems from a coincidental timeline: routine childhood vaccinations are primarily administered between birth and age five, which is also the age window when autism is most commonly diagnosed. This overlap creates a misleading correlation that is often misinterpreted as causation.

    In its 2025 report, the WHO noted that unsubstantiated claims about theoretical vaccine risks have fueled ongoing public controversy, particularly at a time when widespread misinformation and disinformation online has driven growing rates of vaccine hesitancy across much of the world.

  • NSW government promises 2300 more surgeries by mid-2027 amid winter hospital surge

    NSW government promises 2300 more surgeries by mid-2027 amid winter hospital surge

    As New South Wales (NSW) braces for what state leaders call the most challenging three weeks of the winter respiratory season, the Australian state government is moving aggressively to clear a years-long backlog of delayed elective procedures by expanding a specialized, high-efficiency surgical model across public hospitals.

    Launched in late 2025 with a AUD 30 million state investment, High Volume Short Stay (HVSS) units are dedicated hospital wings designed exclusively to handle low-complexity, same or short-day surgeries. Under the new expansion plan, these specialized units will deliver an additional 2,300 routine procedures over the coming 12 months, with the full capacity target expected to be met by July 1, 2027, according to projections from NSW Health.

    State Health Minister Ryan Park explained that the HVSS model is a core pillar of the current government’s pledge to eliminate the state’s long-delayed surgery waitlist, which swelled to a peak of more than 18,000 under the previous state administration. As of March 2026, government data shows the backlog has already been cut to roughly 4,000 cases, marking significant progress in clearing the backlog left by the prior government.

    “We are investing in surgery services across the state, expanding access to care, cutting wait times, and improving patient outcomes,” Park said in a press statement. “These high volume surgical programs are exactly the kind of innovative care we want to see, and I’m looking forward to seeing this model expanded across NSW.”

    The procedures handled by HVSS units cover 80 percent of all routine surgeries performed across NSW’s public health system, spanning common, low-risk procedures across ear, nose and throat care, general surgery, gynecology, urology, ophthalmology, and orthopedics. Currently, the units operate at five strategic locations: Campbelltown in outer western Sydney, Shellharbour, Wagga Wagga, Western NSW, and the Mid North Coast, bringing expanded care access to both metropolitan and regional communities.

    The expansion comes as NSW’s public hospital system grapples with an unprecedented winter surge in patient demand. Last week, Premier Chris Minns issued a public warning that emergency departments across the state were preparing for the “worst three weeks of the year”, urging patients with non-life-threatening conditions to seek care from alternative providers to ease pressure on overstretched emergency teams.

    “To the extent that you can go to an urgent care clinic or see your GP … if it’s not life-threatening, we genuinely suggest that you do that so the doctors can focus and nurses can focus their efforts and attention on people that are about to die,” Minns said.

    The scale of the surge already being felt was underscored by new data: Park confirmed that just under 10,000 patients presented to Sydney emergency departments on Monday, breaking the record for the busiest winter day on record. The state also recorded roughly 4,100 ambulance call-outs on the same day, pushing emergency response systems close to capacity.

    Beyond the seasonal surge, Park has repeated calls for the federal government to intervene to resolve the ongoing “bed block” crisis, which sees hundreds of aged care patients stranded in public hospital beds while waiting for commonwealth-funded aged care support packages. In June, state data showed the number of these so-called stranded patients had jumped to nearly 1,300, further reducing available capacity for acute and emergency care across the state.

  • Congo says 2,000 people have died in its Ebola outbreak, the fastest growing on record

    Congo says 2,000 people have died in its Ebola outbreak, the fastest growing on record

    In the eastern Democratic Republic of Congo, a rapidly spreading Ebola outbreak that has already become the fastest-growing in recorded history has crossed a devastating mortality threshold, with latest official government data confirming at least 2,000 fatalities among confirmed cases. The grim milestone comes as international and local health response teams face overlapping barriers that slow urgent care delivery to remote, conflict-affected communities, leaving the virus far outpacing containment efforts.

    Data released publicly overnight ahead of Tuesday puts the total cumulative confirmed cases at 4,381, with the death toll reaching 2,011. As of the latest update, 704 patients remain isolated and under care for the virus. The scale of the outbreak’s spread has alarmed global health experts: just under three months have passed since the Congolese government officially declared the outbreak on May 15, but the acceleration of deaths shows an alarming upward trajectory. It took nine weeks to record the first 1,000 fatalities, yet only three additional weeks to push the death toll to 2,000, a pace that responders have struggled to match.

    Already, this outbreak ranks as the second-largest Ebola event in global history. It is only surpassed by the 2014-2016 West African epidemic, which infected more than 28,000 people and killed over 11,000 across Guinea, Liberia and Sierra Leone. For the Democratic Republic of Congo, this is the 17th Ebola outbreak the country has confronted since the virus was first identified in 1976 near the Ebola River within the nation’s borders, and it is already the largest the country has ever faced.

    Multiple overlapping crises have undermined containment efforts, according to response officials and aid workers. Active rebel conflict in affected regions makes access to remote communities dangerous at best, while poorly maintained infrastructure leaves many affected areas cut off from rapid medical support. Compounding these issues, hundreds of frontline health workers have launched work stoppages to protest delayed and missing hazard pay promised when the outbreak was declared.

    Adding to the complexity of the response, this outbreak is caused by the rare Bundibugyo Ebola strain, for which no specific approved vaccines or targeted treatments currently exist. Early-stage clinical trials for candidate vaccines and therapies have been launched in Ituri province, the geographic epicenter of the outbreak, but regulatory and logistical delays mean widespread access to these tools remains months away.

    The World Health Organization revealed new findings on Monday that show the outbreak was circulating undetected far earlier than official detection. WHO officials confirmed the virus likely began spreading in February, three months before the formal declaration, in one of Congo’s most underserved and remote regions. Early cases were misdiagnosed as malaria or typhoid, and initial testing only screened for the more common Zaire strain of Ebola, allowing the virus to establish unmonitored transmission in local communities. Today, most new confirmed cases are found among people not already on contact tracing lists, a clear sign that community transmission remains widespread.

    Speaking at a press briefing, Dr. Mohamed Yakub Janabi, WHO’s Regional Director for Africa, summed up the ongoing challenge facing responders: “We are chasing the virus, and the virus is ahead of us.” Aid groups that have expanded response operations across the five affected provinces acknowledge that the outbreak continues to outpace the incremental growth of containment efforts, leaving global health authorities bracing for further increases in case counts and deaths in the coming weeks.

  • Trump order pushes for overhaul of childhood vaccine schedule

    Trump order pushes for overhaul of childhood vaccine schedule

    On a Monday afternoon in the Oval Office, U.S. President Donald Trump signed an executive order calling for a sweeping review of childhood vaccine mandates for K-12 schools, doubling down on a long-debunked call to split the combined measles, mumps, and rubella (MMR) vaccine into three separate single-disease shots. The signing ceremony was attended by Health and Human Services Secretary Robert F. Kennedy Jr., a longstanding anti-vaccine advocate who built his public profile around spreading false claims of a link between childhood immunization and autism, a claim that has been thoroughly disproven by decades of peer-reviewed clinical research.

    Critics across the medical and public health communities have quickly decried the order as scientifically unfounded and a direct threat to decades of successful public health progress. The policy push also faces immediate structural limitations: the federal government holds no direct authority over school vaccine requirements, which are set independently by individual U.S. states and territories. As outlined in the text of the order itself, the Trump administration can only advise state and local governments to revisit their existing immunization rules for school enrollment, making the measure largely symbolic rather than immediately enforceable.

    The order does include one actionable provision: it directs the Department of Health and Human Services to convene a new interagency task force to work with private pharmaceutical manufacturers and international partners to develop and approve separate MMR vaccines, while retaining the existing combined shot as an option. Even if the task force moves forward immediately, leading pediatric health experts warn that full regulatory approval and widespread distribution of separate shots would take more than a decade to complete.

    “This entire order is rooted in politics and conspiracy theories, not evidence-based public health,” Alister Martin, New York City’s Health Commissioner, said in a public statement following the signing. “Vaccination recommendations should not be set by the president, and thankfully, they are not. Cities and states retain authority to set their own rules, and here in New York City, we will continue to follow science-based guidance, not politically motivated misinformation.”

    Decades of large-scale clinical trials and population-level data consistently confirm that the combined MMR vaccine is safe for children. Public health experts note that the combined formulation delivers faster, broader protection against three dangerous contagious diseases, while also reducing logistical burdens for families who may face barriers to scheduling multiple doctor’s appointments for separate shots. Despite this overwhelming consensus, President Trump used the signing ceremony to repeat a series of inflammatory, unsubstantiated claims contradicting established medical guidance.

    Leading national medical organizations have uniformly rejected the administration’s proposals. Andrew Racine, president of the American Academy of Pediatrics (AAP), emphasized that the development process for separate MMR vaccines would take more than 10 years to complete under the best of circumstances. “We are advising all pediatric providers and parents to continue following the existing schedule, which uses a vaccine that has 70 years of proven safety data behind it,” added Aaron M. Milstone, a member of the AAP Committee on Infectious Diseases.

    Even some members of the president’s own party have publicly denounced the move. Senator Bill Cassidy, a physician whose decisive vote confirmed Kennedy’s controversial appointment as Health Secretary, posted to social media platform X that the order would only worsen existing vaccine hesitancy and put American children at greater risk of preventable disease. “This executive order is wrong,” Cassidy wrote. “The President does not have the medical expertise to make these changes. Vaccines are overwhelmingly safe. Vaccines are effective. Vaccines DO NOT cause autism.”

    The latest policy push comes as the Trump administration already saw a prior attempt to overhaul federal vaccine policy blocked by a federal court earlier this year, after major medical organizations successfully argued the administration’s actions violated federal law. A judge issued a stay on the changes pending ongoing legal proceedings.

    Monday’s order arrives at a critical moment: as children across the United States prepare to return to in-person schooling for the new academic year, the country is currently grappling with the worst measles outbreak it has seen in 35 years. Public health officials widely blame rising vaccine hesitancy, fueled in large part by anti-vaccine misinformation spread by Kennedy and other allies of the president, for the resurgence of the once-eliminated disease.

    Recent polling shows a majority of American voters support evidence-based childhood vaccination requirements, and both Kennedy and Trump had softened their anti-vaccine rhetoric in recent months amid fears that hardline anti-vaccine positions would hurt Republican candidates in the upcoming November midterm elections. Monday’s signing makes clear that rolling back existing vaccine policy and advancing anti-vaccine misinformation remains a core priority of the administration’s public health agenda, as both men continue to endorse the thoroughly debunked claim that immunization causes autism.